Credit Suisse Downgrades AbbVie On Humira Competitive Concerns


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


AbbVie Inc (NYSE:ABBV)'s stock is up 51 percent year-over-year, but its lifeblood may be draining.

The Rating

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Credit Suisse analysts Vamil Divan and Michael Morabito downgraded AbbVie to Underperform and lowered their price target from $104 to $89.

The Thesis

The analysts attribute AbbVie’s run to Humira legal settlements and tax reform coupled with high pipeline expectations.

“The first two points have played out but we see pipeline enthusiasm now being stretched, at best limiting room for further upside over the next 12 months,” Divan and Morabito wrote in a note.


FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


They identify long-term fundamental concerns, particularly with emerging competition limiting Humira’s longevity.

The fourth-quarter entry of biosimilars in Europe is seen to catalyze “rapid erosion” of Humira sales, while U.S. earnings are to be stunted by impending biosimilar competition, decreased ability for AbbVie to increase prices, the impact of copay accumulator programs, and action to work around “rebate traps” ahead of rival emergence.

Price Action

AbbVie had popped 3.3 percent Wednesday to $102.92 on unrelated financing news.

Related Links:

Pharma M&A Picks Up Momentum

Novartis Gets Approval For Remicade Biosimilar In Europe


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: Analyst ColorDowngradesPrice TargetAnalyst RatingsCredit SuisseMichael MorabitoVamil Divan